Omega Diagnostics Group PLC US expansion update
January 06 2023 - 02:00AM
UK Regulatory (RNS & others)
TIDMODX
RNS Number : 8680L
Omega Diagnostics Group PLC
06 January 2023
OMEGA DIAGNOSTICS GROUP PLC
("Omega", the "Company" or the "Group")
US expansion update
Maiden US Laboratory FoodPrint(R) installation,
Appointment of US importer for FoodPrint(R) and
First PO from US CLIA certified Lab heralds start of US
expansion
Omega (AIM: ODX), the specialist medical diagnostics company
focused on promoting a personalised and functional approach to
health and nutrition, announces that it has now received the maiden
purchase order ('PO') for its FoodPrint(R) system from a CLIA
certified ('Clinical Laboratory Improvement Amendments') laboratory
in the United States, and has appointed a new US importer for
FoodPrint(R) kits.
Using a small finger prick of blood, the FoodPrint(R) test can
quickly identify an individual's unique food sensitivity reactions,
allowing the patient to adjust and plan to a new diet and address
IgG-mediated food sensitivities. FoodPrint(R) analyses up to 222
foods for IgG antibodies and is trusted by more than 150
laboratories worldwide, to help fast track a guided elimination
diet allowing a more focused and actionable result for
practitioners and their patients.
The Board expects installation at the laboratory to commence
later this month and after a period of validation and gaining
necessary approvals, the processing of tests to begin later this
quarter. As well as being CLIA certified, the laboratory receiving
the system is also College of American Pathologists accredited and
specialises in providing functional tests for both consumers and
healthcare practitioners.
Omega has also secured an importer for FoodPrint(R) kits into
the USA. The importer will import kits for the CLIA laboratory as
well as for Omega's own direct channels in future.
Although the value of this initial PO is circa GBP50,000, the US
market is a key area of focus for Omega's growth strategy and this
installation will be the first in the US market in over seven
years, representing the beginning of Omega's planned expansion into
the USA.
Jag Grewal, CEO of Omega Diagnostics, said: "The US is the
single largest market for food sensitivity testing globally, with
an ever-increasing demand for personalised medicine, and is a focus
area for our growth plans. This installation reflects a key
milestone in our expansion plans, the receiving laboratory is
ideally placed to commercialise FoodPrint(R) in the US market as
they are already providing a range of other functional tests. The
appointment of the US importer will act as a foundation for our
expansion into the region.
"Once the system has been commissioned, we plan to collaborate
closely with our laboratory partner to ensure FoodPrint(R) is
promoted effectively through their existing healthcare practitioner
and direct to consumer channels."
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate
Finance)
Alice Lane/Charlotte Sutcliffe
(ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega (AIM: ODX) is a specialist medical diagnostics company
focused on promoting a personalised and functional approach to
health and nutrition .
www.omegadx.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDBAMLTMTTMBAJ
(END) Dow Jones Newswires
January 06, 2023 02:00 ET (07:00 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Feb 2023 to Mar 2023
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2022 to Mar 2023